Role of nitric oxide and protein kinase C in the tachyphylaxis to vasopressin in rat aortic rings

被引:9
作者
Hamel, C [1 ]
Millette, E [1 ]
Lamontagne, D [1 ]
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
基金
加拿大健康研究院;
关键词
vasopressin; tachyphylaxis; nitric oxide; nNOS; protein kinase C; prostaglandins; epoxyeicosatrienoic acids; rat; aorta;
D O I
10.1016/j.lfs.2004.12.039
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The contribution of endothelium-derived mediators and protein kinase C in the tachyphylaxis to arginine vasopressin (AVP) was assessed in the rat aorta. Endothelium-intact (E+) and denuded rings (E-) obtained from the rat thoracic aorta were exposed to three administrations of a supramaximal concentration of AVP (100 W), lasting 20 min and 45 min apart. N-Omega-nitro-L-arginine (NNLA), a non-selective inhibitor of all isoforms of NO synthase, and AMT, a selective inhibitor for the inducible (iNOS) and neuronal (nNOS) isoforms, diminished the tachyphylaxis to AVP significantly in both E+ and in E- rings. No iNOS could be detected by Western blots in freshly isolated rings or in rings exposed to AVP, despite a strong signal in rings isolated from LPS-treated rats, while nNOS could be constitutively detected. Inhibition of prostaglandins or epoxyeicosatrienoic acids (EETs) synthesis by diclofenac or clotrimazole, respectively, had no effect on tachyphylaxis while combination of these agents diminished tachyphylaxis in E+ only. Combination of NNLA, diclofenac and clotrimazole blocked completely the tachyphylaxis. Inhibition of PKC by either chelerythrine or bisindolylmaleimide I-HCl (BisI) led to a significant diminution of AVP tachyphylaxis only in E-. Activation of PKC with phorbol-12-myristate-13-acetate (PMA) simulated tachyphylaxis to AVP in E- only, effect blocked by the NO donor, SNP. In conclusion, NO produced from constitutive nNOS present in vascular smooth muscle cells participates in tacbyphylaxis to AVR PKC is involved in this tachyphylaxis only in E- rings, the presence of NO probably diminishing the effects of this kinase. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1069 / 1081
页数:13
相关论文
共 27 条
[1]   Nitric oxide modulates β2-adrenergic receptor palmitoylation and signaling [J].
Adam, L ;
Bouvier, M ;
Jones, TLZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26337-26343
[2]   Homologous and heterologous acute desensitization of vasopressin V1a receptor in Xenopus oocytes [J].
Ancellin, N ;
Morel, A .
CELLULAR SIGNALLING, 1998, 10 (03) :217-223
[3]   Homologous and heterologous phosphorylation of the vasopressin V1a receptor [J].
Ancellin, N ;
Preisser, L ;
Le Maout, S ;
Barbado, M ;
Creminon, C ;
Corman, B ;
Morel, A .
CELLULAR SIGNALLING, 1999, 11 (10) :743-751
[4]   Nitric oxide reduces the palmitoylation of rat myelin proteolipid protein by an indirect mechanism [J].
Bizzozero, OA ;
Bixler, H ;
Parkhani, J ;
Pastuszyn, A .
NEUROCHEMICAL RESEARCH, 2001, 26 (10) :1127-1137
[5]   The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes [J].
Boer, R ;
Ulrich, WR ;
Klein, T ;
Mirau, B ;
Haas, S ;
Baur, I .
MOLECULAR PHARMACOLOGY, 2000, 58 (05) :1026-1034
[6]   Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells -: Activation by angiotensin II in hypertension [J].
Boulanger, CM ;
Heymes, C ;
Benessiano, J ;
Geske, RS ;
Lévy, BI ;
Vanhoutte, PM .
CIRCULATION RESEARCH, 1998, 83 (12) :1271-1278
[7]   Desensitization of G-protein-coupled receptors in the cardiovascular system [J].
Bünemann, M ;
Lee, KB ;
Pals-Rylaarsdam, R ;
Roseberry, AG ;
Hosey, MM .
ANNUAL REVIEW OF PHYSIOLOGY, 1999, 61 :169-192
[8]  
BUNNEMANN M, 1999, J PHYSL CAMBRIDGE, V517, P5
[9]   The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension [J].
Chagneau, C ;
Tazi, KA ;
Heller, J ;
Sogni, P ;
Poirel, O ;
Moreau, R ;
Lebrec, D .
JOURNAL OF HEPATOLOGY, 2000, 33 (01) :26-32
[10]   Evidence for the existence of a constitutive nitric oxide synthase in vascular smooth muscle [J].
Cheah, LS ;
Gwee, MCE ;
Das, R ;
Ballard, H ;
Yang, YF ;
Daniel, EE ;
Kwan, CY .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2002, 29 (08) :725-727